CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease.
about
Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical ImplicationsGenome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's diseaseNeuroprotective effect of caffeic acid phenethyl ester in 3-nitropropionic acid-induced striatal neurotoxicityWhen cytokinin, a plant hormone, meets the adenosine A2A receptor: a novel neuroprotectant and lead for treating neurodegenerative disorders?Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter.Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspectiveReduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblasts.miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington's Disease Monkey Neural CellsTransducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease.Acetyltransferases (HATs) as targets for neurological therapeuticsCREB: a multifaceted regulator of neuronal plasticity and protection.Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders.CREB influences timing and entrainment of the SCN circadian clockTAK-063, a Novel Phosphodiesterase 10A Inhibitor, Protects from Striatal Neurodegeneration and Ameliorates Behavioral Deficits in the R6/2 Mouse Model of Huntington's Disease.Ultrastructural and transcriptional profiling of neuropathological misregulation of CREB function.Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies.Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse.
P2860
Q26753116-82D4DB13-F3E0-4220-B0F7-F3A2A6F4081AQ28594357-818C7255-638D-4A6C-B54D-8E0DA422BB92Q28833281-44A97A59-7AD4-4F79-94CD-BCA0D8D77C15Q31067963-7E15B8A6-C587-4E03-A583-2A65F8EA9441Q34284039-9FE0DD23-C978-4588-B0F9-27E5312A45E2Q34994779-31F53E36-F4DC-4B47-8CD0-A560BFBBCB11Q35024695-A724F132-F7B9-4E34-9EE4-9137D3AA0C72Q35125153-DD65C877-4961-414B-A559-9BDBC8296D57Q36133682-D6C96273-8ED3-4378-AE65-D8AF29D8074DQ36379946-2AB92409-BDFA-4182-B6BF-69F35267AFDCQ37249167-917F64E7-7714-4730-B0C6-776A780EE727Q37806285-A439FCAC-9A6D-4AA9-A87A-69E46F003D7BQ38085375-6B45E7DE-C245-4B3F-951A-F19C4A214A7EQ41880479-6DA5B321-24DA-4031-A3EE-B1D1C78BDCBEQ42427377-973520E0-80C4-40CE-B622-CCF8F88FE4CAQ45298693-8E2015A5-E931-47D7-82D0-5E1AC8B1D6D6Q48235161-F040D225-0028-4AA8-ADD1-60144062525EQ54965657-CF402551-111E-43F1-818F-B5D76F775FDAQ55335504-B710EDC3-3051-4D1C-B2EB-9D4DA5466C05
P2860
CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
CREB is a key regulator of str ...... odels of Huntington's disease.
@ast
CREB is a key regulator of str ...... odels of Huntington's disease.
@en
type
label
CREB is a key regulator of str ...... odels of Huntington's disease.
@ast
CREB is a key regulator of str ...... odels of Huntington's disease.
@en
prefLabel
CREB is a key regulator of str ...... odels of Huntington's disease.
@ast
CREB is a key regulator of str ...... odels of Huntington's disease.
@en
P2093
P2860
P1476
CREB is a key regulator of str ...... odels of Huntington's disease.
@en
P2093
Boyoung Lee
Hee-Yeon Cho
Iza B Reyes
Karl Obrietan
Takaomi C Saido
Yun-Sik Choi
P2860
P304
P356
10.1016/J.NBD.2009.07.014
P50
P577
2009-07-24T00:00:00Z